{"entity":{"type":"insider","cik":"0001392402","url":"/insider/0001392402","json_url":"/insider/0001392402.json","name":"RA Capital Healthcare Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":341,"n_filings":34,"first":"2007-03-28","last":"2009-05-11","span_basis":"filed_date"},"name_variants":[{"name":"RA Capital Healthcare Fund II, L.P.","source":"filing","n_filings":12,"first_seen":"2008-11-07","last_seen":"2009-05-11"},{"name":"RA Capital Biotech Fund II, L.P.","source":"filing","n_filings":22,"first_seen":"2007-03-28","last_seen":"2008-11-04"}],"transactions":[{"id":5646248,"accession":"0001209191-09-025859","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-025859","line_url":"/filing/0001209191-09-025859#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15058.0,"shares_display":"15,058","price_per_share":19.47,"price_display":"19.47","price_state":"stated","total_value":293179.26,"total_display":"293,179.26","total_whole":"293,179","shares_owned_after":841603.0,"shares_owned_after_display":"841,603","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-28","filed_date":"2009-05-11","scope":"insider"},{"id":5646247,"accession":"0001209191-09-025859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-025859","line_url":"/filing/0001209191-09-025859#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":19.4,"price_display":"19.40","price_state":"stated","total_value":1940.0,"total_display":"1,940.00","total_whole":"1,940","shares_owned_after":826545.0,"shares_owned_after_display":"826,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-27","filed_date":"2009-05-11","scope":"insider"},{"id":5646246,"accession":"0001209191-09-025859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-025859","line_url":"/filing/0001209191-09-025859#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":601.0,"shares_display":"601","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":11419.0,"total_display":"11,419.00","total_whole":"11,419","shares_owned_after":826445.0,"shares_owned_after_display":"826,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-24","filed_date":"2009-05-11","scope":"insider"},{"id":5597100,"accession":"0001209191-09-022639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-022639","line_url":"/filing/0001209191-09-022639#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":16650.0,"total_display":"16,650.00","total_whole":"16,650","shares_owned_after":825844.0,"shares_owned_after_display":"825,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-14","filed_date":"2009-04-24","scope":"insider"},{"id":5597099,"accession":"0001209191-09-022639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-022639","line_url":"/filing/0001209191-09-022639#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":284.0,"shares_display":"284","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":5126.2,"total_display":"5,126.20","total_whole":"5,126","shares_owned_after":824944.0,"shares_owned_after_display":"824,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-13","filed_date":"2009-04-24","scope":"insider"},{"id":5636143,"accession":"0001209191-09-021540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-021540","line_url":"/filing/0001209191-09-021540#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6419.0,"shares_display":"6,419","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":121961.0,"total_display":"121,961.00","total_whole":"121,961","shares_owned_after":824660.0,"shares_owned_after_display":"824,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-09","filed_date":"2009-04-14","scope":"insider"},{"id":5636142,"accession":"0001209191-09-021540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-021540","line_url":"/filing/0001209191-09-021540#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3301.0,"shares_display":"3,301","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":59418.0,"total_display":"59,418.00","total_whole":"59,418","shares_owned_after":818241.0,"shares_owned_after_display":"818,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-08","filed_date":"2009-04-14","scope":"insider"},{"id":6038143,"accession":"0001209191-09-020847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-020847","line_url":"/filing/0001209191-09-020847#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2432.0,"shares_display":"2,432","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":46208.0,"total_display":"46,208.00","total_whole":"46,208","shares_owned_after":814940.0,"shares_owned_after_display":"814,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-02","filed_date":"2009-04-07","scope":"insider"},{"id":6038140,"accession":"0001209191-09-020847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-020847","line_url":"/filing/0001209191-09-020847#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1577.0,"shares_display":"1,577","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":29174.5,"total_display":"29,174.50","total_whole":"29,175","shares_owned_after":812508.0,"shares_owned_after_display":"812,508","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-01","filed_date":"2009-04-07","scope":"insider"},{"id":5802802,"accession":"0001209191-09-017529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-017529","line_url":"/filing/0001209191-09-017529#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5345.0,"shares_display":"5,345","price_per_share":19.94,"price_display":"19.94","price_state":"stated","total_value":106579.3,"total_display":"106,579.30","total_whole":"106,579","shares_owned_after":810931.0,"shares_owned_after_display":"810,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-17","filed_date":"2009-03-19","scope":"insider"},{"id":5802800,"accession":"0001209191-09-017529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-017529","line_url":"/filing/0001209191-09-017529#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund II, L.P.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":100375.0,"total_display":"100,375.00","total_whole":"100,375","shares_owned_after":805586.0,"shares_owned_after_display":"805,586","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-13","filed_date":"2009-03-19","scope":"insider"},{"id":5693311,"accession":"0001209191-09-015740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-015740","line_url":"/filing/0001209191-09-015740#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":18.8,"price_display":"18.80","price_state":"stated","total_value":47000.0,"total_display":"47,000.00","total_whole":"47,000","shares_owned_after":800086.0,"shares_owned_after_display":"800,086","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-11","filed_date":"2009-03-12","scope":"insider"},{"id":5693310,"accession":"0001209191-09-015740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-015740","line_url":"/filing/0001209191-09-015740#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2150.0,"shares_display":"2,150","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":39237.5,"total_display":"39,237.50","total_whole":"39,238","shares_owned_after":797586.0,"shares_owned_after_display":"797,586","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-10","filed_date":"2009-03-12","scope":"insider"},{"id":5825200,"accession":"0001209191-09-002305","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-002305","line_url":"/filing/0001209191-09-002305","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund II, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5390.0,"shares_display":"5,390","price_per_share":21.634508348794064,"price_display":"21.63","price_state":"stated","total_value":116610.0,"total_display":"116,610.00","total_whole":"116,610","shares_owned_after":792296.0,"shares_owned_after_display":"792,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-31","filed_date":"2009-01-07","scope":"insider","n_lines":3},{"id":3920147,"accession":"0001209191-08-067957","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-08-067957","line_url":"/filing/0001209191-08-067957","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund II, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9700.0,"shares_display":"9,700","price_per_share":21.864329896907215,"price_display":"21.86","price_state":"stated","total_value":212084.0,"total_display":"212,084.00","total_whole":"212,084","shares_owned_after":790046.0,"shares_owned_after_display":"790,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2008-12-31","scope":"insider","n_lines":7},{"id":4003050,"accession":"0001209191-08-067955","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-08-067955","line_url":"/filing/0001209191-08-067955","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.; RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund LP","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":20.571428571428573,"price_display":"20.57","price_state":"stated","total_value":14400.0,"total_display":"14,400.00","total_whole":"14,400","shares_owned_after":780146.0,"shares_owned_after_display":"780,146","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-31","scope":"insider","n_lines":2},{"id":4003047,"accession":"0001209191-08-067955","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-08-067955","line_url":"/filing/0001209191-08-067955","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"Kolchinsky Peter; RA Capital Healthcare Fund II, L.P.; RA CAPITAL MANAGEMENT, LLC; RA Capital Healthcare Fund LP","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":20.234363636363636,"price_display":"20.23","price_state":"stated","total_value":111289.0,"total_display":"111,289.00","total_whole":"111,289","shares_owned_after":778826.0,"shares_owned_after_display":"778,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-22","filed_date":"2008-12-31","scope":"insider","n_lines":6},{"id":2495259,"accession":"0001209191-08-062114","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-062114","line_url":"/filing/0001209191-08-062114#line-5","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; ALDRICH RICHARD","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":887.0,"shares_display":"887","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":13305.0,"total_display":"13,305.00","total_whole":"13,305","shares_owned_after":742196.0,"shares_owned_after_display":"742,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-18","filed_date":"2008-11-21","scope":"insider"},{"id":2495254,"accession":"0001209191-08-062114","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-062114","line_url":"/filing/0001209191-08-062114","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA CAPITAL MANAGEMENT, LLC; Kolchinsky Peter; RA Capital Healthcare Fund LP; RA Capital Healthcare Fund II, L.P.; ALDRICH RICHARD","owner_display_name":"RA CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44000.0,"shares_display":"44,000","price_per_share":16.71590909090909,"price_display":"16.72","price_state":"stated","total_value":735500.0,"total_display":"735,500.00","total_whole":"735,500","shares_owned_after":737309.0,"shares_owned_after_display":"737,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-17","filed_date":"2008-11-21","scope":"insider","n_lines":4},{"id":4038556,"accession":"0001209191-08-060800","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-08-060800","line_url":"/filing/0001209191-08-060800","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund II, L.P.; ALDRICH RICHARD; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14300.0,"shares_display":"14,300","price_per_share":16.465034965034967,"price_display":"16.47","price_state":"stated","total_value":235450.0,"total_display":"235,450.00","total_whole":"235,450","shares_owned_after":688109.0,"shares_owned_after_display":"688,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-14","filed_date":"2008-11-14","scope":"insider","n_lines":5},{"id":4038540,"accession":"0001209191-08-060800","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-08-060800","line_url":"/filing/0001209191-08-060800","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund II, L.P.; ALDRICH RICHARD; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24165.0,"shares_display":"24,165","price_per_share":16.70811090420029,"price_display":"16.71","price_state":"stated","total_value":403751.5,"total_display":"403,751.50","total_whole":"403,752","shares_owned_after":683009.0,"shares_owned_after_display":"683,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-14","scope":"insider","n_lines":6},{"id":4038519,"accession":"0001209191-08-060800","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-060800","line_url":"/filing/0001209191-08-060800","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":null,"owner_name":"RA Capital Healthcare Fund II, L.P.; ALDRICH RICHARD; RA Capital Healthcare Fund LP; Kolchinsky Peter; RA CAPITAL MANAGEMENT, LLC","owner_display_name":"RA Capital Healthcare Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.444,"price_display":"15.44","price_state":"stated","total_value":154440.0,"total_display":"154,440.00","total_whole":"154,440","shares_owned_after":658844.0,"shares_owned_after_display":"658,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-14","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2008-11-12|4038513","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875622","name":"BIOSPECIFICS TECHNOLOGIES CORP","url":"/issuer/0000875622","role":"Ten percent owner","n_filings":15,"first_seen":"2008-09-26","last_seen":"2009-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001013238","name":"ARADIGM CORP","url":"/issuer/0001013238","role":"Ten percent owner","n_filings":6,"first_seen":"2007-09-13","last_seen":"2008-10-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001076481","name":"SEQUENOM INC","url":"/issuer/0001076481","role":"Ten percent owner","n_filings":10,"first_seen":"2008-06-13","last_seen":"2008-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001108205","name":"CURIS INC","url":"/issuer/0001108205","role":"Ten percent owner","n_filings":1,"first_seen":"2008-04-17","last_seen":"2008-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000071478","name":"LIPID SCIENCES INC/","url":"/issuer/0000071478","role":"Ten percent owner","n_filings":2,"first_seen":"2007-03-28","last_seen":"2008-03-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001392402","retrieved_at":"2026-08-25T18:48:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}